| Type | Dynamic characteristic | Number | Cytokines | Compared to the beginning by paired -test, falling within the range at week | | | |
| 1 | Sharp increase | 7 | TNF RII | | 2, 4, 10 | 6, 12, 16 | CXCL8/IL8 | | 2, 4, 6, 10 | 12, 16 | IL10 | 6, 12, 16 | 2, 4 | 10 | CCL5/RANTES | 16 | 2, 4, 10, 12 | 6 | CXCL4 | 6 | 2, 10, 12 | 4, 16 | CXCL10 | 6, 16 | 2, 4, 10, 12 | | CXCL13 | 2, 4, 6, 10, 16 | 12 | |
| 2 | Moderate increase | 8 | IFN-gamma | | 2, 4, 12 | 6, 10, 16 | TNF-alpha | | 2, 4, 6, 10, 16 | 12 | GM-CSF | | 2, 4, 6, 10 | 12, 16 | IL-1 beta | | 4, 10, 12, 16 | 2, 6 | IL4 | | 2, 6, 12, 16 | 4, 10 | IL17A | | 2, 4, 6 | 10, 12, 16 | CXCL12/SDF-1 alpha | | 12, 16 | 2, 4, 6, 10 | CD40 | 6, 10 | 4, 16 | 2, 12 |
| 3 | Slight increase | 8 | TNF RI | | 2, 6, 16 | 4, 10, 12 | IL2 | 6 | | 2, 4, 10, 12, 16 | IL15 | | 2, 10 | 4, 6, 12, 16 | IL22 | | | 2, 4, 6, 10, 12, 16 | CCL2 | 4 | 10 | 2, 6, 12, 16 | CCL13 | | 4, 6 | 2, 10, 12, 16 | CCL22 | 16 | 12 | 2, 4, 6, 10 | Galectin-3bp | | 4, 6, 12, 16 | 2, 10 |
| 4 | A transient increase | 7 | IL6 | | 2 | 4, 6, 10, 12, 16 | CCL18 | 2 | 4 | 6, 10, 12, 16 | CCL27 | | | 2, 4, 6, 10, 12, 16 | CXCL1/GRO alpha | | 4 | 2, 6, 10, 12, 16 | CD27 | | 4, 10 | 2, 6, 12, 16 | B7-H1/PD-L1/CD274 | 4 | | 2, 6, 10, 12, 16 | MIF | | 12 | 2, 4, 6, 10, 16 |
| 5 | Multipeak kinetics | 6 | IL1 RA | 6 | 16 | 2, 4, 10, 12 | IL1 RII | | 2 | 4, 6, 10, 12, 16 | IL23 | | 12 | 2, 4, 6, 10, 16 | CCL4 | | | 2, 4, 6, 10, 12, 16 | CCL7 | | 12 | 2, 4, 6, 10, 16 | CCL11 | 4, 12 | | 2, 6, 10, 16 |
| 6 | No specific changes | 8 | IL2 R alpha | | | 2, 4, 6, 10, 12, 16 | IL5 | | | 2, 4, 6, 10, 12, 16 | IL6 R alpha | | | 2, 4, 6, 10, 12, 16 | IL19 | | | 2, 4, 6, 10, 12, 16 | CD14 | | | 2, 4, 6, 10, 12, 16 | CD30 | | | 2, 4, 6, 10, 12, 16 | CD56 | | | 2, 4, 6, 10, 12, 16 | MPO | | | 2, 4, 6, 10, 12, 16 |
|
|